Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 604-721-7 | CAS number: 150114-71-9
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Eye irritation
Administrative data
- Endpoint:
- eye irritation: in vivo
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 15 June 2001 to 30 August 2001
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- test procedure in accordance with generally accepted scientific standards and described in sufficient detail
- Remarks:
- Study conducted to GLP in compliance with agreed protocols, with no or minor deviations from standard test guidelines and/or minor methodological deficiencies, which do not affect the quality of the relevant results.
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 001
- Report date:
- 2001
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 405 (Acute Eye Irritation / Corrosion)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.5 (Acute Toxicity: Eye Irritation / Corrosion)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EPA OPPTS 870.2400 (Acute Eye Irritation)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- other: JMAFF Primary Eye Irritation Study, 2000
- Deviations:
- no
- GLP compliance:
- yes
Test material
- Reference substance name:
- 4-amino-3,6-dichloropyridine-2-carboxylic acid
- EC Number:
- 604-721-7
- Cas Number:
- 150114-71-9
- Molecular formula:
- C6H4Cl2N2O2
- IUPAC Name:
- 4-amino-3,6-dichloropyridine-2-carboxylic acid
- Test material form:
- solid: particulate/powder
- Details on test material:
- - Appearance: tan powder
Constituent 1
- Specific details on test material used for the study:
- Purity: 94.5%
Test animals / tissue source
- Species:
- rabbit
- Strain:
- New Zealand White
- Details on test animals or tissues and environmental conditions:
- TEST ANIMALS
- Age at study initiation: 20 - 21 weeks
- Weight at study initiation: 2.7 - 2.8 kg
- Housing: animals were housed individually in stainless steel cages
- Diet: animals received 5 oz. per day
- Water: ad libitum
- Acclimation period: at least 2 weeks
- Other: The eyes of three adult New Zealand White rabbits were examined with 2 % aqueous fluorescein stain and established as being free of defects/irritation the day prior to the study.
ENVIRONMENTAL CONDITIONS
- Temperature: 19 ± 3 °C
- Humidity: 40 - 60 % (relative)
- Air changes: 12 - 15 air changes per hour
- Photoperiod: 12 hours of darkness / 12 hours of light (06:00 to 18:00)
Test system
- Vehicle:
- unchanged (no vehicle)
- Controls:
- other: The left eye of each rabbit remained untreated and served as a control.
- Amount / concentration applied:
- A 0.1 g aliquot of the test material in powder form was instilled into each of the treated eyes.
- Duration of treatment / exposure:
- The eyelid of each rabbit was held closed for approximately one second after dosing.
- Observation period (in vivo):
- 1, 24, 48 and 72 hours and 7, 14, 21, 28, and 35 days post-instillation
- Number of animals or in vitro replicates:
- Three
- Details on study design:
- Test material was instilled into the conjunctival sac of the right eye of three rabbits.
The behaviour of each rabbit was observed immediately post-treatment for indications of pain or discomfort. An ocular anaesthetic was used for both eyes of one rabbit on days 2, 3, and 4.
SCORING SYSTEM:
Irritation was scored according to the Draize scale (below):
> Cornea
Opacity: degree of density (area most dense is taken for reading).
0 = No ulceration or opacity
1 = Scattered or diffuse areas of opacity (except for slight dulling of normal lustre), details of iris clearly visible
2 = Easily discernible translucent area, details of iris slightly obscured
3 = Nacreous area, no details of iris visible, size of pupil barely discernible
4 = Opaque cornea, iris not discernible through the opacity
> Conjunctivae
Redness: (refers to the most severe effect of palpebral and bulbar conjunctivae in comparison to the control eye)
0 = Blood vessels normal
1 = Some blood vessels definitely hyperaemic (injected)
2 = Diffuse crimson colour, individual vessels not easily discernible
3 = Diffuse beefy red
Chemosis: lids and/or nictating membranes
0 = No swelling
1 = Any swelling above normal (includes nictating membranes)
2 = Obvious swelling with partial eversion of lids.
3 = Swelling with lids about half closed
4 = Swelling with lids more than half closed
Discharge
0 = No discharge
1 = Any amount different from normal (does not include small amounts observed in inner canthus of normal animals)
2 = Discharge with moistening of the lids and hairs just adjacent to lids
3 = Discharge with moistening of the lids and hairs a considerable area around the eye
> Iris
0 = Normal
1 = Markedly deepened rugae, congestion, swelling, moderate circumcorneal hyperaemia or injection; any of these or combination of any thereof, iris still reacting to light (sluggish reaction is positive)
2 = No reaction to light, haemorrhage, gross destruction (any or of all these)
TOOL USED TO ASSESS SCORE:
Both eyes of the rabbits were examined with a binocular loupe and a white halogen light at approximately 1, 24, 48, and 72 hours and 7, 14, 21, 28, and 35 days post-instillation for conjunctival redness and chemosis, discharge, corneal opacity, and reddening of the iris. A cobalt blue light was used to assess the corneas of all rabbits following fluorescein stain application at various times during the study.
OTHER EXAMINATIONS
Rabbits were weighed on the day of treatment and study termination.
Results and discussion
In vivo
Resultsopen allclose all
- Irritation parameter:
- cornea opacity score
- Basis:
- animal #1
- Time point:
- 24/48/72 h
- Score:
- 2
- Max. score:
- 4
- Reversibility:
- not fully reversible within: 35 days
- Irritation parameter:
- cornea opacity score
- Basis:
- animal #2
- Time point:
- 24/48/72 h
- Score:
- 2
- Max. score:
- 4
- Reversibility:
- fully reversible within: 21 days
- Irritation parameter:
- cornea opacity score
- Basis:
- animal #3
- Time point:
- 24 h
- Score:
- 2
- Max. score:
- 4
- Irritation parameter:
- cornea opacity score
- Basis:
- animal #3
- Time point:
- other: 48/72 h
- Score:
- 1
- Max. score:
- 4
- Reversibility:
- fully reversible within: 21 days
- Irritation parameter:
- iris score
- Basis:
- animal #1
- Time point:
- 24 h
- Score:
- 0
- Max. score:
- 2
- Irritation parameter:
- iris score
- Basis:
- animal #1
- Time point:
- other: 48/72 h
- Score:
- 1
- Max. score:
- 2
- Reversibility:
- fully reversible within: 7 days
- Irritation parameter:
- iris score
- Basis:
- animal #2
- Time point:
- 24/48/72 h
- Score:
- 1
- Max. score:
- 2
- Reversibility:
- fully reversible within: 14 days
- Irritation parameter:
- iris score
- Basis:
- animal #3
- Time point:
- 24/48/72 h
- Score:
- 1
- Max. score:
- 2
- Reversibility:
- fully reversible within: 7 days
- Irritation parameter:
- chemosis score
- Basis:
- animal #1
- Time point:
- 24/48/72 h
- Score:
- 3
- Max. score:
- 4
- Reversibility:
- not fully reversible within: 35 days
- Irritation parameter:
- chemosis score
- Basis:
- animal #2
- Time point:
- 24 h
- Score:
- 2
- Max. score:
- 4
- Irritation parameter:
- chemosis score
- Basis:
- animal #2
- Time point:
- other: 48/72 h
- Score:
- 1
- Max. score:
- 4
- Reversibility:
- fully reversible within: 21 days
- Irritation parameter:
- chemosis score
- Basis:
- animal #3
- Time point:
- 24 h
- Score:
- 3
- Max. score:
- 4
- Irritation parameter:
- chemosis score
- Basis:
- animal #3
- Time point:
- other: 48/72 h
- Score:
- 2
- Max. score:
- 4
- Reversibility:
- fully reversible within: 21 days
- Irritant / corrosive response data:
- One hour after dosing, all rabbits had slight conjunctival redness, moderate chemosis, and moderate discharge. Twenty-four hours after dosing, all rabbits had moderate to marked conjunctival redness, moderate chemosis, moderate to marked discharge, and slight corneal opacity. The two male rabbits also had slight irritation of the iris twenty-four hours after dosing. Forty-eight hours after dosing, all rabbits had moderate to marked conjunctival redness, slight to moderate chemosis, moderate to marked discharge, slight corneal opacity, and slight irritation of the iris. The ocular irritation slowly diminished over time. Corneal vascularisation was noted in all three animals starting on day 15 and continuing for one rabbit through day 36. Two rabbits had ocular irritation that continued through study termination.
- Other effects:
- All rabbits gained body weight over the duration of the study.
Any other information on results incl. tables
Table 1: Individual Animal Irritation Grades
Observation time after dosing |
Animal no. |
Redness |
Conjunctival chemosis |
Discharge |
Corneal opacity |
Reddening of iris |
24 hours |
01A3957 |
2 |
3 |
2 |
2 |
0 |
01A3955 |
3 |
2 |
3 |
2 |
1 |
|
01A3956 |
3 |
3 |
3 |
2 |
1 |
|
48 hours |
01A3957 |
2 |
3 |
2 |
2 |
1 |
01A3955 |
2 |
1 |
1 |
2 |
1 |
|
01A3956 |
3 |
2 |
2 |
1 |
1 |
|
72 hours |
01A3957 |
3 |
3 |
2 |
2 |
1 |
01A3955 |
2 |
1 |
1 |
2 |
1 |
|
01A3956 |
3 |
2 |
2 |
1 |
1 |
Irritation parameter |
Time Point |
Mean score |
Max score |
Reversibility |
Corneal opacity score |
24, 48, and 72 hours |
1.78 |
4 |
Not fully reversible within 35 days |
Iris score |
24, 48, and 72 hours |
0.89 |
2 |
Fully reversible within 14 days |
Chemosis score |
24, 48, and 72 hours |
2.22 |
4 |
Not fully reversible within 35 days |
Conjunctival redness |
24, 48, and 72 hours |
2.56 |
3 |
Not fully reversible within 35 days |
Conjunctival discharge |
24, 48, and 72 hours |
2 |
3 |
Fully reversible within 28 days |
Applicant's summary and conclusion
- Interpretation of results:
- Category 1 (irreversible effects on the eye)
- Conclusions:
- Under the conditions of the study, the animals displayed moderate to marked signs of ocular irritation which lessened over time but effects on the cornea, conjunctiva and chemosis persisted to study termination 35 days post-instillation.
- Executive summary:
The eye irritation potential of the test material was investigated in a study which was conducted under GLP conditions and in accordance with the standardised guidelines OECD 405, EPA OPPTS 870.2400, EU Method B.5 and JMAFF (2000).
During the study aliquots of 0.1 g of neat test material in powder form were placed into the conjunctival sac of the right eye of one female and two male New Zealand White rabbits. An ocular anaesthetic was used for both eyes of one rabbit on days 2, 3, and 4.
One hour after dosing, all rabbits had slight conjunctival redness, moderate chemosis, and moderate discharge. Twenty-four hours after dosing, all rabbits had moderate to marked conjunctival redness, moderate chemosis, moderate to marked discharge, and slight corneal opacity. The two male rabbits also had slight irritation of the iris twenty-four hours after dosing. Forty-eight hours after dosing, all rabbits had moderate to marked conjunctival redness, slight to moderate chemosis, moderate to marked discharge, slight corneal opacity, and slight irritation of the iris. The ocular irritation slowly diminished over time. Corneal vascularisation was noted in all three animals starting on day 15 and continuing for one rabbit through day 36. Two rabbits had ocular irritation that continued through study termination. All rabbits gained body weight over the duration of the study.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
